Factors Predicting Response to Progestin Treatment for Complex Atypical Hyperplasia/Well Differentiated Endometrial Carcinoma in Premenopausal Patients.

被引：0
|
作者：
Aoyama, C.
Penner, K.
Ostrzega, N.
Rao, J.
Walsh, C.
Dorigo, O.
Cass, I.
Balzer, B.
Holschneider, C.
机构：
[1] Olive View UCLA Med Ctr, Sylmar, CA USA
[2] UCLA Med Ctr, Los Angeles, CA USA
[3] Cedar Sinai Med Ctr, Los Angeles, CA USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
997
引用
收藏
页码：236A / 236A
页数：1
相关论文
共 50 条
  • [21] Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia
    Zhang, Qing
    Qi, Gonghua
    Kanis, Margaux J.
    Dong, Ruifen
    Cui, Baoxia
    Yang, Xingsheng
    Kong, Beihua
    ONCOTARGET, 2017, 8 (34) : 57642 - 57653
  • [22] Multi-institutional study identifying predictors of response to progestin treatment of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma
    Penner, K.
    Dorigo, O.
    Walsh, C.
    Cass, I.
    Holschneider, C.
    GYNECOLOGIC ONCOLOGY, 2008, 111 (02) : 379 - 379
  • [23] Factors affect the outcome of IVF and the recurrence of the endometrial disease of patients with atypical endometrial hyperplasia (AEH) and early well-differentiated endometrial adenocarcinoma (EC)
    Li, H.
    Song, X.
    Li, R.
    Qiao, J.
    HUMAN REPRODUCTION, 2018, 33 : 251 - 251
  • [24] Factors affect the outcome of IVF and the recurrence of the endometrial disease of patients with atypical endometrial hyperplasia (AEH) and early well-differentiated endometrial adenocarcinoma(EC)
    Li, H.
    Song, X.
    Li, R.
    Qiao, J.
    HUMAN REPRODUCTION, 2018, 33 : 251 - 251
  • [25] Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin
    Simpson, Andrea N.
    Feigenberg, Tomer
    Clarke, Blaise A.
    Gien, Lilian T.
    Ismiil, Nadia
    Laframboise, Stephane
    Massey, Christine
    Ferguson, Sarah E.
    GYNECOLOGIC ONCOLOGY, 2014, 133 (02) : 229 - 233
  • [26] Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response
    Tierney, Katherine E.
    Ji, Lingyun
    Dralla, Shannon S.
    Yoo, Eunjeong
    Yessaian, Annie
    Pham, Huyen Q.
    Roman, Lynda
    Sposto, Richard
    Mhawech-Fauceglia, Paulette
    Lin, Yvonne G.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (03) : 650 - 654
  • [27] Fractal Dimension as a Diagnostic Tool of Complex Endometrial Hyperplasia and Well-differentiated Endometrioid Carcinoma
    Bikou, Olga
    Delides, Alexander
    Drougou, Aggeliki
    Nonni, Afroditi
    Patsouris, Efstratios
    Pavlakis, Kitty
    IN VIVO, 2016, 30 (05): : 681 - 690
  • [28] Clinical Predictive Factors of Response to Treatment in Patients Undergoing Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer
    Raffone, Antonio
    Travaglino, Antonio
    Flacco, Maria Elena
    Iasevoli, Mara
    Mollo, Antonio
    Guida, Maurizio
    Insabato, Luigi
    Sardo, Attilio Di Spiezio
    Carugno, Jose
    Zullo, Fulvio
    JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2021, 10 (02) : 193 - 201
  • [29] Reproductive Outcomes of a Cohort of Women Undergoing Conservative Progestin Therapy for Complex Atypical Hyperplasia or Grade 1 Endometrial Carcinoma
    Kudesia, Rashmi
    Singer, Tomer
    Kligman, Isaac
    Caputo, Thomas C.
    Gupta, Divya
    Rosenwaks, Zev
    REPRODUCTIVE SCIENCES, 2012, 19 (S3) : 337A - 337A
  • [30] A practical guideline on the fertility-sparing treatment of patients with endometrial carcinoma and atypical endometrial hyperplasia
    Catena, Ursula
    Macklon, Kirsten Louise Tryde
    Rodolakis, Alexandros
    Scambia, Giovanni
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2025,
12345